O'rourke M F, Namasivayam M, Adji A
St Vincent's Clinic, University of New South Wales, Sydney, Australia.
Minerva Med. 2009 Feb;100(1):25-38.
Isolated systolic hypertension (ISH) is present in the majority of persons who reach the age of 80 years, and is caused directly or indirectly by stiffening of the aorta and large central elastic arteries. Until recently, there was no consensus on whether or not persons over 80 should be treated, according to principles established for the younger group examined in the Systolic Hypertension in the Elderly Project (SHEP). The recent Hypertension in the Very Elderly Trial (HYVET) study endorses application of SHEP to most such subjects. This review describes the background to SHEP and HYVET, including concepts of hypertension and interpretation of blood pressure values. It describes the effects of age on arterial stiffness, and effects of stiffness on the heart, large arteries and microvessels in brain and kidneys as the basis of symptomatic disease. It describes logic of therapy with newer antihypertensives which indirectly affect arterial stiffness and form the basis of therapy in older persons. It proposes how, with what and in whom antihypertensive therapy could be offered in persons over age 80.
大多数80岁以上的人患有单纯收缩期高血压(ISH),其直接或间接由主动脉和大的中心弹性动脉僵硬所致。直到最近,对于是否应根据老年收缩期高血压计划(SHEP)中针对较年轻群体确立的原则来治疗80岁以上的人,尚无共识。最近的高龄老人高血压试验(HYVET)研究支持将SHEP应用于大多数此类受试者。本综述描述了SHEP和HYVET的背景,包括高血压的概念和血压值的解读。它描述了年龄对动脉僵硬的影响,以及僵硬对心脏、大动脉以及脑和肾微血管的影响,这些是症状性疾病的基础。它描述了使用新型抗高血压药物进行治疗的原理,这些药物间接影响动脉僵硬,是老年人治疗的基础。它提出了如何、用什么以及对哪些80岁以上的人提供抗高血压治疗。